Kezar Life Sciences Cash from Investing (Quarterly) Trends

Kezar Life Sciences Inc (KZR)

0.7633 0.00 (0.00%) USD | NASDAQ | May 17, 16:00

0.7633 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	20.41M
December 31, 2023	27.88M
September 30, 2023	18.57M
June 30, 2023	13.20M
March 31, 2023	16.39M
December 31, 2022	-8.661M
September 30, 2022	-24.71M
June 30, 2022	1.51M
March 31, 2022	-59.53M
December 31, 2021	-82.49M
September 30, 2021	38.48M
June 30, 2021	16.25M
March 31, 2021	-0.687M
December 31, 2020	17.32M
September 30, 2020	2.79M

Date	Value
June 30, 2020	-37.28M
March 31, 2020	-39.33M
December 31, 2019	1.678M
September 30, 2019	15.62M
June 30, 2019	2.142M
March 31, 2019	0.976M
December 31, 2018	-9.916M
September 30, 2018	-56.67M
June 30, 2018	-17.12M
March 31, 2018	-0.195M
December 31, 2017	-0.063M
September 30, 2017	-0.326M
June 30, 2017	0.00
March 31, 2017	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-82.49M

Minimum

Dec 2021

38.48M

Maximum

Sep 2021

-3.022M

Average

2.466M

Median

Cash from Investing (Quarterly) Benchmarks

Accuray Inc	-0.795M
Tonix Pharmaceuticals Holding Corp	-0.108M
Acumen Pharmaceuticals Inc	-9.203M
NovaBay Pharmaceuticals Inc	1.068M
Palatin Technologies Inc	0.00

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-22.86M
Free Cash Flow	-83.65M
Free Cash Flow Per Share (Quarterly)	-0.314
Free Cash Flow Yield	-150.3%